0001171843-20-005951.txt : 20200814
0001171843-20-005951.hdr.sgml : 20200814
20200814161520
ACCESSION NUMBER: 0001171843-20-005951
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200814
FILED AS OF DATE: 20200814
DATE AS OF CHANGE: 20200814
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Shameze Rampertab
CENTRAL INDEX KEY: 0001721810
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38298
FILM NUMBER: 201105253
MAIL ADDRESS:
STREET 1: C/O ZOMEDICA PHARMACEUTICALS CORP.
STREET 2: 3928 VARSITY DRIVE
CITY: ANN ARBOR
STATE: MI
ZIP: 48108
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Zomedica Pharmaceuticals Corp.
CENTRAL INDEX KEY: 0001684144
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: A0
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 100 PHOENIX DRIVE
STREET 2: SUITE 180
CITY: ANN ARBOR
STATE: MI
ZIP: 48108
BUSINESS PHONE: (734) 369-2555
MAIL ADDRESS:
STREET 1: 100 PHOENIX DRIVE
STREET 2: SUITE 180
CITY: ANN ARBOR
STATE: MI
ZIP: 48108
4
1
ownership.xml
X0306
4
2020-08-14
1
0001684144
Zomedica Pharmaceuticals Corp.
ZOM
0001721810
Shameze Rampertab
C/O ZOMEDICA PHARMACEUTICALS CORP.
100 PHOENIX DRIVE, SUITE 180
ANN ARBOR
MI
48018
0
0
0
1
Former CFO and Director
The reporting ceased to be a director effective August 6, 2020 and ceased to be an executive officer effective August 14, 2020. As a result, the reporting person is no longer subject to Section 16 in connection with his transactions in the equity securities of Zomedica Pharmaceuticals Corp. and therefore will no longer report any such transactions on Form 4 or Form 5.
/s/ Shameze Rampertab
2020-08-14